Cargando…
IL-32 promotes breast cancer cell growth and invasiveness
Interleukin (IL)-32 is a newly identified cytokine in humans and primates. It has been established that IL-32 may antagonize cancer growth. However, to the best of our knowledge, the direct effect of IL-32 on breast cancer cell growth has not yet been investigated. In addition, rodents lack the expr...
Autores principales: | WANG, SHOUMAN, CHEN, FEIYU, TANG, LILI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246643/ https://www.ncbi.nlm.nih.gov/pubmed/25435980 http://dx.doi.org/10.3892/ol.2014.2641 |
Ejemplares similares
-
Association Between Single-Nucleotide Polymorphisms in Breast Cancer Susceptibility Genes and Clinicopathological Characteristics
por: Wang, Shouman, et al.
Publicado: (2021) -
METTL3-mediated m(6)A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis
por: Zhou, Zhiyang, et al.
Publicado: (2023) -
Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32
por: Takagi, Kohji, et al.
Publicado: (2020) -
IL-32 and IL-34 in hepatocellular carcinoma
por: Si, Yang, et al.
Publicado: (2022) -
IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines
por: Zhu, XingWu, et al.
Publicado: (2008)